151 related articles for article (PubMed ID: 37946746)
1. Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report.
Endo M; Fukuda Y; Okada K; Ogawa K; Nakamura M; Takahashi S; Kawahara M; Akahane K; Nagai Y; Yamaguchi H; Nishino H; Mori H; Shirai K
Case Rep Oncol; 2023; 16(1):1345-1352. PubMed ID: 37946746
[TBL] [Abstract][Full Text] [Related]
2. The abscopal effect in head-and-neck squamous cell carcinoma treated with radiotherapy and nivolumab: a case report and literature review.
Forner D; Horwich P; Trites JR; Hollenhorst H; Bullock M; Lamond NWD
Curr Oncol; 2020 Dec; 27(6):330-335. PubMed ID: 33380865
[TBL] [Abstract][Full Text] [Related]
3. Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.
Takehara Y; Mimura K; Suzuki Y; Watanabe Y; Yoshimoto Y; Saze Z; Sato H; Tamaki T; Kono K
Cancer Rep (Hoboken); 2023 Jul; 6(7):e1832. PubMed ID: 37165926
[TBL] [Abstract][Full Text] [Related]
4. Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
McBride S; Sherman E; Tsai CJ; Baxi S; Aghalar J; Eng J; Zhi WI; McFarland D; Michel LS; Young R; Lefkowitz R; Spielsinger D; Zhang Z; Flynn J; Dunn L; Ho A; Riaz N; Pfister D; Lee N
J Clin Oncol; 2021 Jan; 39(1):30-37. PubMed ID: 32822275
[TBL] [Abstract][Full Text] [Related]
5. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
[TBL] [Abstract][Full Text] [Related]
6. Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma-a case report.
Cerbon D; Moya-Brown K; Mihaylov IB; Spieler B
Front Oncol; 2023; 13():1143335. PubMed ID: 37182135
[TBL] [Abstract][Full Text] [Related]
7. Overcoming immune-resistance in laryngeal cancer: a case report of the abscopal effect and nivolumab beyond progression.
Marco F; Gianluca A; Mariagrazia T; Luca EP
Immunotherapy; 2022 Oct; 14(14):1089-1095. PubMed ID: 36040238
[TBL] [Abstract][Full Text] [Related]
8. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A
Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323
[TBL] [Abstract][Full Text] [Related]
9. Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy.
Kim JS; Chang AR
Front Oncol; 2023; 13():1243053. PubMed ID: 37869087
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Masini C; Iotti C; De Giorgi U; Bellia RS; Buti S; Salaroli F; Zampiva I; Mazzarotto R; Mucciarini C; Vitale MG; Bruni A; Lohr F; Procopio G; Caffo O; Nole F; Morelli F; Baier S; Buttigliero C; Ciammella P; Timon G; Fantinel E; Carlinfante G; Berselli A; Pinto C
Eur Urol; 2022 Mar; 81(3):274-282. PubMed ID: 34602312
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
[TBL] [Abstract][Full Text] [Related]
12. A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.
Bestvina CM; Pointer KB; Karrison T; Al-Hallaq H; Hoffman PC; Jelinek MJ; Juloori A; Melotek JM; Murgu S; Partouche J; Vokes EE; Weichselbaum RR; Pitroda SP; Patel JD; Chmura SJ
J Thorac Oncol; 2022 Jan; 17(1):130-140. PubMed ID: 34500113
[TBL] [Abstract][Full Text] [Related]
13. Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report.
Fiorica F; Belluomini L; Giuliani J; Urbini B; Milella M; Frassoldati A; Pilotto S; Giorgi C
Immunotherapy; 2021 Aug; 13(12):971-976. PubMed ID: 34180714
[TBL] [Abstract][Full Text] [Related]
14. True abscopal effect in a patient with metastatic non-small cell lung cancer.
Vilinovszki O; Andratschke N; Huellner M; Curioni-Fontecedro A; Kroeze SGC
Radiat Oncol; 2021 Oct; 16(1):194. PubMed ID: 34600561
[TBL] [Abstract][Full Text] [Related]
15. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
[TBL] [Abstract][Full Text] [Related]
17. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Kim S; Wuthrick E; Blakaj D; Eroglu Z; Verschraegen C; Thapa R; Mills M; Dibs K; Liveringhouse C; Russell J; Caudell JJ; Tarhini A; Markowitz J; Kendra K; Wu R; Chen DT; Berglund A; Michael L; Aoki M; Wang MH; Hamaidi I; Cheng P; de la Iglesia J; Slebos RJ; Chung CH; Knepper TC; Moran-Segura CM; Nguyen JV; Perez BA; Rose T; Harrison L; Messina JL; Sondak VK; Tsai KY; Khushalani NI; Brohl AS
Lancet; 2022 Sep; 400(10357):1008-1019. PubMed ID: 36108657
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy-induced abscopal effect twice after pembrolizumab failure in hereditary leiomyomatosis and renal cell carcinoma: a case report with genetic and immunologic analysis.
Zhang X; Zhang Y; Liu Y; Yang Y; Dong P; He L; Zhou F
Transl Androl Urol; 2021 Nov; 10(11):4304-4312. PubMed ID: 34984195
[TBL] [Abstract][Full Text] [Related]
19. Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report.
Bonomo P; Lucidi S; Desideri I; Scotti V; Casati M; Palomba A; Ciabatti C; Garlatti P; Massi D; Gallo O; Livi L
Clin Transl Radiat Oncol; 2020 Jul; 23():16-19. PubMed ID: 32368625
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab for recurrent/metastatic hypopharyngeal squamous cell carcinoma in a liver transplant recipient.
Kondo T; Kawachi S; Nakatsugawa M; Takeda A; Kikawada N; Aihara Y; Okimura A; Hirano H; Ogawa Y; Tsukahara K
Auris Nasus Larynx; 2022 Aug; 49(4):721-726. PubMed ID: 33612350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
